| ||
| Why tumours resist cancer drugs Adelaide Now Molecular biologist Professor David Wang, who worked on the research, said the scientists focused on how two drugs, Taxol and Vincristine, work. Both are often used to treat breast and ovarian cancer. Other research in an accompanying paper, ... See all stories on this topic » | ||
| Inside Wall Street: How Goldman Is Playing the Coming Tide of Generic Drugs DailyFinance The branded drug is produced by Eli Lilly (LLY). Gemzar sales will be a big boost to Amerisource this year, the analysts say. Taxotere, a generic drug for breast and prostate cancer, "will be the biggest near-term catalyst for distributors such as ... See all stories on this topic » | ||
| Diabetes Ups Death Risk Overall, Study Shows U.S. News & World Report Moreover, they were 25 percent more likely to die from cancer, with scientists finding a moderate association between the disease and death from liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, and lung, bladder or breast cancer. ... See all stories on this topic » | ||
| Letters: A scam; SnoBusters; Planned Parenthood Bennington Banner ... result in a million additional unplanned pregnancies resulting in 400000 more abortions, according to the Guttmacher Institute, as well as needless suffering from preventable reproductive tract infections, including cervical and breast cancer. ... See all stories on this topic » | ||
| In Thursday's newspaper Vancouver Sun Successful personalized cancer care requires a global collaborative effort so that diverse populations of cancer patients have the opportunity to participate in clinical trials and are treated with the latest innovative drugs which target the products ... See all stories on this topic » | ||
| OVERNIGHT HEALTH: Anti-fraud proposals target doctors, Cuba The Hill (blog) FDA weighs in on breast implant risks: The Food and Drug Administration has asked two plastic surgery organizations to discontinue webinars that appeared to downplay the link between breast implants and a rare form of cancer. Who's watching granny? ... See all stories on this topic » | ||
| Scientists target aggressive prostate cancer Bioscience Technology But the gene is an ideal target for a monoclonal antibody, the same type of drug as Herceptin, which is aimed at HER2 and has dramatically improved treatment for this aggressive type of breast cancer. "Since SPINK1 can be made on the surface of cells, ... See all stories on this topic » | ||
|
| ||
| Breast cancer drug benefits questioned | 6minutes Experts are questioning why expensive aromatase inhibitor drugs are being widely used in preference to tamoxifen when they do not increase overall survival. 6minutes RSS - http://www.6minutes.com.au/ | ||
| Oncothyreon (NASDAQ: ONTY) $106M (MarketCap) Back in the Game as ... By admin These consisted of two lung cancer trials known as Start and Inspire as well as a breast cancer study called Stride. The three trials, all of which involve the BLP25 liposomal vaccine (Stimuvax), consisted of a combined 2600 patients. ... Oncothyreon has no marketed products, but it has other cancer drugs in its pipeline besides the BLP25-based immune booster. Its partner, Merck, is primarily responsible for the development of this program, while Oncothyreon, ... Bio Technology - http://www.ctba.us/ | ||
| F.D.A. Orders Prescription Cold Drugs Pulled From Market ... By By ANDREW POLLACK F.D.A. Grants Hearing on Avastin as Treatment for Breast Cancer. The Food and Drug Administration has granted a hearing for Genentech to argue in favor of preserving the approval of its drug Avastin as a treatment for breast cancer. ... Prescriptions - http://prescriptions.blogs.nytimes.com/ |
| ||
| New Chemo Drug May Benefit Some Breast Cancer Patients - iVillage Eribulin increased median survival by 2.5 months in those with metastatic disease, study finds. www.ivillage.com/328408/4-a-328408 | ||
| Breast Cancer Topic: Survivors who have used only alternative ... Because chemotherapy is given with support drugs, the trials also have not ..... One of the reasons the death rates for breast cancer have gone down is not ... community.breastcancer.org/forum/79/topic/765299?page=7 | ||
| Breast Cancer Experts Foresee Changes in 2011 - The ASCO Post Clearly, multiple factors affect sensitivity to existing drugs, and these are currently are not well understood. With triple-negative breast cancer, ... www.ascopost.com/.../breast-cancer-experts-foresee-changes-i... |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment